Korean J Psychopharmacol.
2000 Jun;11(2):178-187.
Augmentation of Regional Cerebral Blood Flow Response by Repeated Administration of Methamphetamine in Rat
- Affiliations
-
- 1Department of Neuropsychiatry, Maryknoll General Hospital, Pusan, Korea.
- 2National Institute of Scientific Investigation, Seoul, Korea.
- 3Department of Pharmacology, College of Medicine, Pusan National University, Pusan, Korea.
Abstract
OBJECTIVES
It was aimed to observe the regional cerebral blood flow (rCBF) response on
methamphetamine challenge test in rats which were subjected to repeated administration
of methamphetamine, and to investigate the mechanism(s) of changes in rCBF response in
relation to the dopaminergic receptors and cyclic AMP.
METHODS
Male Sprague-Dawley rats received daily injections of methamphetamine
(0.3 mg/kg, i.p.) for 10 days, and were then allowed a 4-day drug-free period. Naive and
methamphetamine-pretreated rats were challenged with topical application of methamphetamine
on the surface of parietal cortex through a cranial window. The changes in rCBF were
measured by laser-Doppler flowmetry.
RESULTS
Acute topical application of methamphetamine dose-dependently increased rCBF with
little effect on mean arterial blood pressure. The methamphetamine-induced increases in
rCBF were significantly blocked by SCH23390, a D1-like receptor antagonist, but not by
sulpiride, a D2-like receptor antagonist. Repeated administration of methamphetamine
induced progressive augmentation of rCBF in response to the challenge of methamphetamine.
Repeated administration of methamphetamine in combination with SKF38393, a D1-like receptor
agonist, as well as with SCH23390 significantly attenuated the development of augmentation
of rCBF response to methamphetamine. The augmentation of rCBF response was markedly
inhibited by pretreatment with 2',3'-dideoxyadenosine, a specific adenylyl cyclase inhibitor,
and Rp-cAMPS, a protein kinase A inhibitor, respectively.
CONCLUSION
Based on these results, it is suggested that repeated administration of
methamphetamine induces an augmentation of rCBF in response to the challenge of
methamphetamine, and that D1-like receptor-mediated cyclic AMP plays a critical role in the
development of augmentation of methamphetamine-induced rCBF response.